Related Experiment Video

Updated: Jun 10, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.5K

Treatment of Autosomal-Dominant Polycystic Kidney Disease

Sara S Jdiaa1, Reem A Mustafa2, Alan S L Yu2

  • 1Division of Nephrology, University of Toronto, Toronto, ON, Canada.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|October 18, 2024
PubMed

Insights

Autosomal-dominant polycystic kidney disease (ADPKD) management focuses on identifying rapid progression risk. Current strategies include lifestyle changes, blood pressure control, and Tolvaptan, with new treatments emerging.

Area of Science:

  • Nephrology
  • Genetics
  • Internal Medicine

Background:

  • Autosomal-dominant polycystic kidney disease (ADPKD) is a leading cause of end-stage kidney disease affecting diverse populations.
  • ADPKD presents with heterogeneous phenotypes, necessitating risk stratification for personalized therapeutic decisions.
  • Predictive tools for ADPKD severity incorporate imaging, genetic, and clinical factors.

Purpose of the Study:

  • To review current understanding and management strategies for ADPKD.
  • To highlight tools for identifying patients at risk of rapid disease progression.
  • To discuss emerging therapeutic interventions for ADPKD.

Main Methods:

  • Review of existing literature and clinical trial data on ADPKD management.
  • Analysis of tools for predicting ADPKD progression, including MRI-based kidney volume and eGFR.
  • Evaluation of lifestyle modifications, blood pressure control, and pharmacologic treatments like Tolvaptan.

Main Results:

  • Intensive blood pressure control, as supported by the HALT PKD trial, is crucial for patients with preserved kidney function.
  • Lifestyle modifications such as weight management, salt restriction, and smoking cessation are beneficial.
  • Tolvaptan is an effective disease-modifying agent for high-risk ADPKD patients, despite potential side effects.

Conclusions:

  • Accurate identification of ADPKD patients at risk of rapid progression is key to guiding treatment.
  • A multi-faceted approach combining lifestyle, blood pressure management, and targeted pharmacotherapy is essential.
  • Ongoing research into novel interventions offers hope for improved ADPKD outcomes.

Keywords:
Kidney volumepolycystic kidney diseasevasopressin

More Related Videos

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

9.7K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

500

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
142
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
1
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...